| | | | | |
CHRS Coherus Oncology, Inc. Common Stock | $1,3200 | -3,65% | $219,39M | $840,61K | |
| $2,6600 | -4,66% | $217,47M | $2,39K | |
MFM Aberdeen Municipal Income Fund | $5,2000 | -1,33% | $217,47M | $265,49K | |
CHCI Comstock Holding Companies, Inc. Class A | $20,7800 | -0,91% | $217,46M | $126,48K | |
PTAC Patriot Acquisition Corp. Class A Ordinary Shares | $9,9800 | +0,40% | $217,43M | $6,10K | |
ARMP Armata Pharmaceuticals, Inc. Common Stock | $5,4100 | -7,04% | $217,14M | $17,88K | |
EXFY Expensify, Inc. Class A Common Stock | $2,2900 | -3,38% | $217,02M | $419,38K | |
| $63,3850 | +0,63% | $216,79M | $16,98K | |
IIF Morgan Stanley India Investment Fund, Inc. | $22,6200 | -0,83% | $216,64M | $13,91K | |
VYGR Voyager Therapeutics, Inc. Common Stock | $3,2500 | -4,41% | $216,27M | $500,54K | |
MITT TPG Mortgage Investment Trust, Inc. | $6,6800 | -1,47% | $216,26M | $283,44K | |
| $1,6000 | +2,56% | $215,73M | $2,88M | |
PEPG PepGen Inc. Common Stock | $3,1700 | -1,25% | $215,39M | $1,15M | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2,6400 | -0,38% | $215,12M | $580,58K | |
GSHR Gesher Acquisition Corp. II Class A Ordinary Shares | $10,5100 | -0,38% | $214,97M | $50,17K | |
